{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-001153","form_type":"8-K","ticker":null,"cik":"0001522860","company_name":"Acutus Medical, Inc.","filed_at":"2024-01-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.485086+00:00","generated_at":"2026-06-07T00:32:22.967982+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Acutus Medical appoints Takeo Mukai as CEO; David Roman becomes consultant","bullets":["David Roman departed as president and CEO effective Jan 7, 2024; also resigned from board.","Takeo Mukai, formerly CFO, appointed CEO effective Jan 8, 2024, retaining CFO role.","Mukai's base salary increased from $325,000 to $375,000; target bonus raised to 60% of base.","Roman entered consulting agreement at $200/hour through Dec 31, 2024 to assist with transition and strategic options.","Board size set at seven members."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-001153","json":"https://secwatch.observer/filing/0001628280-24-001153.json","markdown":"https://secwatch.observer/filing/0001628280-24-001153.md","text":"https://secwatch.observer/filing/0001628280-24-001153.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1522860/000162828024001153/0001628280-24-001153-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1522860/000162828024001153/afib-20240107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T00:32:22.967982+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"02c4c1c85a","claim":"David Roman departed as President and Chief Executive Officer at Acutus Medical, Inc..","evidence_excerpt":"David Roman was expected to depart from his position as president and chief executive officer of the Company, as part of the Company’s strategic realignment of resources and corporate restructuring, which departure became effective January 7, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1522860/000162828024001153/0001628280-24-001153-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"departed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"812753e1ae","claim":"David Roman resigned as Member of the Board of Directors at Acutus Medical, Inc..","evidence_excerpt":"Mr. Roman has also resigned as a member of the Company’s board of directors effective January 7, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1522860/000162828024001153/0001628280-24-001153-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Member of the Board of Directors"}],"fact_type":"executive_change"},{"claim_id":"ec0ee2b4c9","claim":"Takeo Mukai was appointed as Chief Executive Officer at Acutus Medical, Inc..","evidence_excerpt":"the Company’s board of directors approved the appointment of Takeo Mukai, the Company’s chief financial officer, as the Company’s chief executive officer, which appointment became effective January 8, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1522860/000162828024001153/0001628280-24-001153-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}